Tirofiban [clinicaltrials_resource:aeaeeb395f1c909095660f01ad15ff44]
Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI [clinicaltrials:NCT00229515]Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180) [clinicaltrials:NCT00251576]clinicaltrials:NCT00306228clinicaltrials:NCT00383136Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel Resistance [clinicaltrials:NCT00398463]The Effects of Tirofiban in Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention [clinicaltrials:NCT00407771]clinicaltrials:NCT00445263GPIIbIIIa Inhibitors in the RESCUe and RESURCOR Networks at the Acute Myocardial Infarction [clinicaltrials:NCT00538317]Safety of High-dose Tirofiban During Coronary Angioplasty [clinicaltrials:NCT00566891]The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction [clinicaltrials:NCT00611169]Shanghai Registry of Acute Coronary Events [clinicaltrials:NCT00713557]Tirofiban and Enoxaparin in High Risk Coronary Intervention [clinicaltrials:NCT00790387]Tirofiban Intracoronary Bolus-only Versus Intravenous Bolus Plus Infusion in STEMI Patients [clinicaltrials:NCT01109134]Impacts of Superselective Infarct-related Artery (IRA) Infusion of Tirofiban on Myocardial Reperfusion and Bleeding Complications in Acute Myocardial Infarction (AMI) Patients [clinicaltrials:NCT01181388]Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention [clinicaltrials:NCT01245725]Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse [clinicaltrials:NCT01336348]clinicaltrials:NCT01498003clinicaltrials:NCT01522417The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft Patency [clinicaltrials:NCT01598337]clinicaltrials:NCT01660373clinicaltrials:NCT01696110clinicaltrials:NCT01766154Intracoronary Tirofiban on No-Reflow Phenomena [clinicaltrials:NCT02054000]clinicaltrials:NCT02131220Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease [clinicaltrials:NCT02294994]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Tirofiban [clinicaltrials_resource:aeaeeb395f1c909095660f01ad15ff44]
Bio2RDF identifier
aeaeeb395f1c909095660f01ad15ff44
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:aeaeeb395f1c909095660f01ad15ff44
identifier
clinicaltrials_resource:aeaeeb395f1c909095660f01ad15ff44
title
Tirofiban
@en
type
label
Tirofiban [clinicaltrials_resource:aeaeeb395f1c909095660f01ad15ff44]
@en